Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Sales	$ 0	$ 100,024	$ 1,623,260	$ 2,756,103
Cost of sales	133,931	80,283	1,245,149	1,739,005
Gross profit	(133,931)	19,741	378,111	1,017,098
Operating expenses
General and administrative	1,395,921	2,578,727	6,056,919	6,785,405
Consulting	55,000	(13,312)	55,000	207,930
Research and development	20,470	46,734	152,351	175,546
Goodwill impairment charge	0	3,392,129	0	3,392,129
Total operating expenses, net	1,471,391	6,004,278	6,264,270	10,561,010
Loss from operations	(1,605,322)	(5,984,537)	(5,886,159)	(9,543,912)
Other (expense)/income:
Interest (expense) income, net	(30,874)	(2,647)	(38,084)	43,455
Unrealized gain (loss) on financial instruments at fair value	403,625	0	(595,783)	0
Other expense	(2,415)	(1,239)	(2,415)	(9,903)
Total other (expense)/income	370,336	(3,886)	(636,282)	33,552
Loss before income taxes	(1,234,986)	(5,988,423)	(6,522,441)	(9,510,360)
Income tax expense	0	0	0	0
Net loss	$ (1,234,986)	$ (5,988,423)	$ (6,522,441)	$ (9,510,360)
Net loss per share to common stockholders:
Basic and diluted (in dollars per share)	$ (0.08)	$ (0.4)	$ (0.41)	$ (0.63)
Weighted shares used in the computation of net loss per share:
Basic and diluted (in shares)	16,302,177	15,068,208	15,872,826	15,036,967